These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

880 related items for PubMed ID: 12938731

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
    Goedert M.
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun 29; 354(1386):1101-18. PubMed ID: 10434313
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Frontotemporal dementia with tau pathology.
    Gasparini L, Terni B, Spillantini MG.
    Neurodegener Dis; 2007 Jun 29; 4(2-3):236-53. PubMed ID: 17596718
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains.
    Ferrer I, Barrachina M, Puig B.
    Acta Neuropathol; 2002 Dec 29; 104(6):658-64. PubMed ID: 12410387
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of tau protein isoforms.
    Tolnay M, Sergeant N, Ghestem A, Chalbot S, De Vos RA, Jansen Steur EN, Probst A, Delacourte A.
    Acta Neuropathol; 2002 Oct 29; 104(4):425-34. PubMed ID: 12200631
    [Abstract] [Full Text] [Related]

  • 13. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H, Grigoriadis N, Eldar-Levy H, Avital A, Rozenstein L, Touloumi O, Behar L, Ben-Hur T, Avraham Y, Berry E, Segal M, Ginzburg I, Abramsky O.
    Exp Neurol; 2008 Jul 29; 212(1):71-84. PubMed ID: 18490011
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Dynamic neuropathology of tauopathy].
    Murayama S.
    Rinsho Shinkeigaku; 2001 Dec 29; 41(12):1101-3. PubMed ID: 12235808
    [Abstract] [Full Text] [Related]

  • 16. [Neuropathology of tauopathy].
    Yoshida M.
    Brain Nerve; 2013 Dec 29; 65(12):1445-58. PubMed ID: 24323931
    [Abstract] [Full Text] [Related]

  • 17. Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies.
    Ferrer I, Hernández I, Boada M, Llorente A, Rey MJ, Cardozo A, Ezquerra M, Puig B.
    Acta Neuropathol; 2003 Nov 29; 106(5):419-35. PubMed ID: 12955398
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tauopathy models and human neuropathology: similarities and differences.
    Frank S, Clavaguera F, Tolnay M.
    Acta Neuropathol; 2008 Jan 29; 115(1):39-53. PubMed ID: 17786456
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.